ATCC Presentations

Attend our AMP Corporate Workshop to learn more about the importance of data provenance in genomics and ATCC’s approach to producing high-quality, authenticated reference genomes.

In this workshop, we highlighted how state-of-the-art ATCC drug-resistant cancer cell models created by CRISPR gene-editing technology can facilitate the discovery of new types of therapeutics that overcomes drug resistance.

In this presentation, Dr. Clinton provided an overview of the Human Cancer Models Initiative (HCMI) and the technologies driving the development of next-generation models.

In this workshop presentation, we discuss the importance of credible reference materials in microbial genomics with a particular focus on microbiome and phylogenetic studies. We also preview ATCC’s genome portal of high-quality assembled genomes for advancing the authentication of ATCC strains.

ATCC molecular signature panels focus on key components of cell signaling pathways such as EGFR, AKT, PI3K, PTEN, or p53. This presentation describes how we generated these panels using authenticated cell lines containing critical gene copy number changes and site mutations.

In this collaborative discussion, microbiome experts discuss the hurdles that microbiome researchers face during each stage of the workflow, challenges and solutions in the development and application of microbiome standards, and current gaps and future trends in microbiome research.

In this presentation, we explore the development of fungal community standards for mycobiome research and demonstrate the utility of these standards in evaluating DNA extraction and sequencing methods for mycobiome analysis.

Mutations in several of the enzymes in the PI3K pathway have been implicated in the pathogenesis of several types of cancer. In this presentation, we discuss the development and application of several cell panels comprising tumor cell lines that feature mutations along the PI3K pathway.

ATCC Human telomerase (hTERT) immortalized cell lines combine the in vivo nature of primary cells and the long culture life of continuous cell lines. This presentation provides an overview of the hTERT-immortalized cell line collection at ATCC.

ATCC has a wide selection of induced pluripotent and mesenchymal stem cells along with an array of associated culture media and reagents. This presentation provides an overview of the ATCC stem cell collection and describe how these resources can be used in cell biology studies.

The complexities involved in metagenomics methods often result in the introduction of biases throughout the workflow, ultimately impacting data interpretation and reproducibility. This workshop highlights the importance of standards in facilitating assay standardization and optimization in microbiome research.

One of the primary obstacles in standardizing metagenomics assays in microbiome research is the limited availability of reference materials and robust analytical tools. In this workshop, we discuss the development of mock microbial communities and explore their application as standards in microbiome research.

Developing cell-based assays can be problematic; the cells must be physiologically relevant for the assay to be predictive, yet sufficiently abundant to be included in the assay without introducing interexperimental variability. In this presentation, ATCC experts discussed the characteristics and utility of various respiratory, skin, and kidney models in toxicological assays.

In this presentation, Dr. Riojas will briefly describe who ATCC and BEI Resources are and will detail our responses to recent infectious disease threats.

This presentation highlights the importance of the authenticity and traceability of genomic data and details ATCC's approach to whole-genome sequencing, assembly, and genome annotation for producing high-quality, authenticated reference genomes.

This presentation examines the use of ATCC materials in molecular-based assays for cancer detection and analysis and assay development for infectious diseases.

ATCC offers a superior lipid-based transfection reagent (TransfeX) that can be used to transfect difficult cell types, like primary and stem cells, and uncomplicated continuous cell lines. In this presentation, we show how TransfeX provides higher transfection efficiency and lower cytotoxicity than other commercially available transfection reagents.